396 related articles for article (PubMed ID: 33392085)
1. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
Front Oncol; 2020; 10():590352. PubMed ID: 33392085
[TBL] [Abstract][Full Text] [Related]
2. Identification of an IFN-β-associated gene signature for the prediction of overall survival among glioblastoma patients.
Cheng L; Yuan M; Li S; Lian Z; Chen J; Lin W; Zhang J; Zhong S
Ann Transl Med; 2021 Jun; 9(11):925. PubMed ID: 34350240
[TBL] [Abstract][Full Text] [Related]
3. A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses.
Cao M; Cai J; Yuan Y; Shi Y; Wu H; Liu Q; Yao Y; Chen L; Dang W; Zhang X; Xiao J; Yang K; He Z; Yao X; Cui Y; Zhang X; Bian X
Cancer Biol Med; 2019 Aug; 16(3):595-605. PubMed ID: 31565488
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
Zhao J; Wang L; Wei B
Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
[TBL] [Abstract][Full Text] [Related]
5. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
6. Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma.
Yuan Q; Zuo FX; Cai HQ; Qian HP; Wan JH
Front Genet; 2022; 13():912227. PubMed ID: 35873494
[No Abstract] [Full Text] [Related]
7. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
[TBL] [Abstract][Full Text] [Related]
9. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
10. Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization.
Liang R; Zhi Y; Zheng G; Zhang B; Zhu H; Wang M
Onco Targets Ther; 2019; 12():157-168. PubMed ID: 30613154
[TBL] [Abstract][Full Text] [Related]
11. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
12. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
[TBL] [Abstract][Full Text] [Related]
13. Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma.
Long S; Wu B; Yang L; Wang L; Wang B; Yan Y; Jiang J; Yang B; Zhou Q; Shi M; Liang W; Wei W; Li X
Front Neurol; 2023; 14():1054686. PubMed ID: 37153654
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
Front Oncol; 2019; 9():1433. PubMed ID: 31921684
[No Abstract] [Full Text] [Related]
15. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
16. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq.
Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
[TBL] [Abstract][Full Text] [Related]
19. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
Wei B; Wang L; Zhao J
Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
[TBL] [Abstract][Full Text] [Related]
20. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]